↓ Skip to main content

Cochrane Database of Systematic Reviews

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
130 Mendeley
Title
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd007419.pub3
Pubmed ID
Authors

Virgili G, Parravano M, Menchini F, Brunetti M, Gianni Virgili, Mariacristina Parravano, Francesca Menchini, Massimo Brunetti, Virgili, Gianni, Parravano, Mariacristina, Menchini, Francesca, Brunetti, Massimo

Abstract

Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk of visual loss in DMO or clinically significant macular oedema (CSMO), vision is rarely improved. Antiangiogenic therapy with anti-vascular endothelial growth factor (anti-VEGF) modalities has recently been proposed for improving vision in people with DMO.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
Ecuador 1 <1%
Austria 1 <1%
Brazil 1 <1%
Canada 1 <1%
Singapore 1 <1%
China 1 <1%
Spain 1 <1%
United States 1 <1%
Other 0 0%
Unknown 120 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 17%
Student > Master 22 17%
Student > Bachelor 18 14%
Student > Ph. D. Student 13 10%
Student > Postgraduate 11 8%
Other 23 18%
Unknown 21 16%
Readers by discipline Count As %
Medicine and Dentistry 62 48%
Agricultural and Biological Sciences 11 8%
Nursing and Health Professions 7 5%
Biochemistry, Genetics and Molecular Biology 6 5%
Unspecified 4 3%
Other 15 12%
Unknown 25 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2013.
All research outputs
#16,874,917
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#11,474
of 13,156 outputs
Outputs of similar age
#187,029
of 287,251 outputs
Outputs of similar age from Cochrane database of systematic reviews
#166
of 197 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,251 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.